de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Impressum Kontakt Einloggen
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Purification, crystallization and preliminary X-ray diffraction analysis of the human major histocompatibility antigen HLA-B*2703 complexed with a viral peptide and with a self-peptide

MPG-Autoren
http://pubman.mpdl.mpg.de/cone/persons/resource/persons94115

Loll,  Bernhard
Department of Biomolecular Mechanisms, Max Planck Institute for Medical Research, Max Planck Society;

Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Loll, B., Zawacka, A., Biesiadka, J., Rueckert, C., Volz, A., Saenger, W., et al. (2005). Purification, crystallization and preliminary X-ray diffraction analysis of the human major histocompatibility antigen HLA-B*2703 complexed with a viral peptide and with a self-peptide. Acta Crystallographica Section F: Structural Biology and Crystallization Communications, 61(4), 372-374. doi:10.1107/S1744309105007438.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-0019-9BF1-6
Zusammenfassung
The product of the human leukocyte antigen (HLA) gene HLA−B*2703 differs from that of the prototypical subtype HLA−B*2705 by a single amino acid at heavy−chain residue 59 that is involved in anchoring the peptide N−terminus within the A pocket of the molecule. Two B*2703−peptide complexes were crystallized using the hanging−drop vapour−diffusion method using PEG 8000 as a precipitant. The crystals belong to space group P21 (pVIPR peptide) or P212121 (pLMP2 peptide). Data sets were collected to 1.55 Å (B*2703−pVIPR) or 2.0 Å (B*2703−pLMP2) resolution using synchrotron radiation. With B*2705−pVIPR as a search model, a clear molecular−replacement solution was found for both B*2703 complexes